Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRF plus liposomal bupivacaine versus PRF plus bupivacaine for zoster-associated pain
ChiCTR2400093669Phase 4Completed
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Dec 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine and bupivacaine in herpes zoster (HZ) (2 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoint: Numeric Rating Scale pain score. Started Dec 2024; status: completed.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2400093669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093669.